Home Plasma nitrite/nitrate concentrations in patients with schizophrenia
Article
Licensed
Unlicensed Requires Authentication

Plasma nitrite/nitrate concentrations in patients with schizophrenia

  • Vladimir V. Djordjević , Ivana Stojanović , Dragana Stanković-Ferlež , Tatjana Ristić , Dušan Lazarević , Vladan Ćosić and Vidosava B. Djordjević
Published/Copyright: January 1, 2010

Abstract

Background: Nitric oxide (NO) is known to be a signaling molecule with many physiogical functions including apoptotic process regulation. Since apoptosis may contribute to the pathophysiology of schizophrenia, this study was undertaken to determine the plasma concentrations of NO in schizophrenics.

Methods: Nitrite/nitrate (NO2/NO3) concentrations were measured in plasma from 40 patients with schizophrenia, and 36 age- and gender-matched healthy persons using a colorimetric test.

Results: Plasma NO2/NO3 concentrations were significantly higher in patients with schizophrenia (102.8±34.7 μmol/L, p<0.0001) than in controls (69.2±13.2 μmol/L). Also, mean NO2/NO3 values in female patients and controls were significantly higher (118.2±44.7 μmol/L, p<0.001; 74.8±16.1 μmol/L, p<0.05, respectively) compared to males (94.7±25.3 μmol/L, 67.6±10.8 μmol/L). Significant correlation was seen between plasma NO2/NO3 concentrations and heredity, number of episodes and peripheral blood mononuclear cell (PBMC) caspase-3 activity, which was significantly higher in patients than in controls (p<0.05). There was no significant difference in NO2/NO3 concentrations between patients with different Positive and Negative Syndrome Scale (PANSS) scores or between patients treated with haloperidol (97.2±31.2 μmol/L) and those treated with other atypical antipsychotic drugs (109.8±33.7 μmol/L). Both parameters showed no significant differences between smokers and non-smokers.

Conclusions: This study showed that plasma NO2/NO3 concentrations were significantly increased in patients with schizophrenia, being significantly higher in female than male patients, and showing a significant correlation with heredity, number of episodes and PBMC caspase-3 activity. These results suggest that NO could be considered an inducer or regulator of apoptosis in patients with schizophrenia.

Clin Chem Lab Med 2010;48:89–94.


Corresponding author: Prof. Dr. Vidosava B. Djordjević, PhD, Institute of Biochemistry, Faculty of Medicine, Bul. dr Zorana Djindjića 81, 18000 Niš, Serbia

Received: 2009-5-9
Accepted: 2009-9-10
Published Online: 2010-01-01
Published in Print: 2010-01-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype?
  3. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement
  4. Reviews
  5. Pandemic influenza A (H1N1) 2009: the experience of the first six months
  6. The role of anti-core antibody response in the detection of occult hepatitis B virus infection
  7. Opinion Papers
  8. Managing quality vs. measuring uncertainty in the medical laboratory
  9. Collective opinion paper on findings of the 2009 convocation of experts on quality control
  10. General Clinical Chemistry and Laboratory Medicine
  11. Diagnostic performance of rapid influenza antigen assays in patients infected with the new influenza A (H1N1) virus
  12. Achieving continuous improvement in laboratory organization through performance measurements: a seven-year experience
  13. Evaluation of errors in a clinical laboratory: a one-year experience
  14. Validation and Outcome Studies
  15. Analytical validation of serum bone alkaline phosphatase (BAP OSTASE) on Liaison
  16. Analytical performance of the serum free light chain assay
  17. A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage
  18. Plasma nitrite/nitrate concentrations in patients with schizophrenia
  19. Inverse relationship between serum high density lipoprotein and negative syndrome in antipsychotic-naive schizophrenia
  20. Reference Values and Biological Variations
  21. Biological variation of free plasma amino acids in healthy individuals
  22. Differences in serum potassium concentrations between Chinese, Indians and Malays
  23. Determination of median levels of the free β subunit of human chorionic gonadotropin in women from mainland China using a new time-resolved fluoroimmunoassay
  24. Age- and gender-specific reference ranges for serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations on the Immulite 2500: results of the Study of Health in Pomerania (SHIP)
  25. Cardiovascular Diseases
  26. Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial
  27. Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness
  28. Letters to the Editor
  29. Serum total and free sialic acid in patients with chronic liver disease
  30. Measurement of nitrotyrosine in plasma by immunoassays is fraught with danger: commercial availability is no guarantee of analytical reliability
  31. Problems with the determination of nitrotyrosine in human plasma are not solved in a satisfactory way and conclusions from clinical trials need to be carefully revised
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.014/html
Scroll to top button